On January 6, 2021 Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) reported its management will be presenting at and attending the following upcoming conferences in the first quarter of 2021 (Press release, Evotec, JAN 6, 2021, View Source;announcements/press-releases/p/evotec-to-attend-upcoming-investor-conferences-6016 [SID1234573623]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

J.P. Morgan 39th Annual Healthcare Conference 2021
Date: Monday, 11 January – Thursday, 14 January 2021, Presentation: Tuesday, 12 January, 7.30 am EST (1.30 pm CET, 12.30 pm GMT, 4.30 am PST)
Venue: Virtual
Attendee: Werner Lanthaler, Chief Executive Officer
Commerzbank German Investment Seminar
Date: Wednesday, 13 January 2021
Venue: Virtual
Attendee: Werner Lanthaler, Chief Executive Officer
UniCredit Kepler Cheuvreux German Corporate Conference
Date: Wednesday, 20 January 2021, Presentation: Wednesday, 20 January, 12 pm CET
Venue: Virtual
Attendee: Werner Lanthaler, Chief Executive Officer
BioCapital Europe
Date: Thursday, 11 March 2021
Venue: Virtual
Attendee: Enno Spillner, Chief Financial Officer